Study On The Performance And Safety Of The LEDINBIO CE Device On Visual Acuity In Subjects With Cataract

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

January 4, 2025

Study Completion Date

February 2, 2025

Conditions
Age-related Cataract
Interventions
DEVICE

Treated with Ledinbio device

Treated with Ledinbio device

Trial Locations (11)

300012

Opticlass Ophthalmology Clinic, Timișoara

300173

CF Timisoara Clinical Hospital, Timișoara

LV-3401

Lens-L Ltd, Liepāja

LV-1050

Dr.Solomatina Acu Centrs, Riga

LV - 3601

Zielmelkurzeme Regional Hospital, Ventspils

Unknown

The Hospital of Lithuanian University of Health Sciences (LSMU) Kauno klinikos, Department of Ophthalmology, Kaunas

Vilnius University Hospital Santaros Klinikos, Center of Eye Diseases, Vilnius

Spitalul Clinic de Urgențe Oftalmologice, Depatement of Ophthamology, Bucharest

"Vedis Ophthalmology Clinic , Ophthalmological Center Dr. Samoila"

Clinica de Oftalmologie Dr. Berghian, Timișoara

Clinica Vista, Ophtalmology Department, Timișoara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

MDX Research

NETWORK

lead

Edinburgh Biosciences Ltd

INDUSTRY